Seqens unveils PeptiCode HP-9, a biotechnological hexapeptide-9 for cosmetic formulations.
Seqens announces the launch of PeptiCode HP-9, Europe's first biotechnological Hexapeptide-9, developed via the PeptiCode biotechnology platform located in Nîmes, France. This platform specializes in the optimization of various microorganisms, including bacteria, yeast and microalgae, through strain engineering and fermentation technologies to access safe and innovative naturally-derived peptides.
Development via precision fermentation
PeptiCode HP-9 is produced by precision fermentation, using the capacity of an optimized microorganism to synthesize a pure hexapeptide-9, of natural and bio-identical 100 % origin. Seqens' process respects the principles of green engineering, guaranteeing high performance and optimal peptide stability without the use of trifluoroacetic acid (TFA) or per- and polyfluoroalkyl substances (PFAS) during production.
Product applications and benefits
PeptiCode HP-9 is designed for long-lasting anti-aging formulations, acting as a signal peptide to stimulate collagen synthesis. Easy to use and interchangeable with its synthetic counterpart, PeptiCode HP-9 is a direct substitute that avoids chemical synthesis, while guaranteeing a high-performance, environmentally-friendly product.
